D
Blonder Tongue Laboratories, Inc. BDRL
OTC PK
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2022 09/30/2022
Revenue 0.30% 24.28%
Total Other Revenue -- --
Total Revenue 0.30% 24.28%
Cost of Revenue -16.40% 21.42%
Gross Profit 46.02% 32.83%
SG&A Expenses -8.53% -1.51%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses -13.68% 10.41%
Operating Income 168.63% 50.62%
Income Before Tax 112.80% 39.08%
Income Tax Expenses -- --
Earnings from Continuing Operations 112.80% 39.08%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 112.80% 39.08%
EBIT 168.63% 50.62%
EBITDA 176.82% 51.60%
EPS Basic 112.71% 39.22%
Normalized Basic EPS 112.73% 39.11%
EPS Diluted 112.71% 41.44%
Normalized Diluted EPS 112.73% 39.11%
Average Basic Shares Outstanding 0.11% 0.12%
Average Diluted Shares Outstanding 0.11% 0.12%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings